Related Experiment Video

Updated: May 25, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Treatment of hepatitis C in dialysis patients

Nuria Esforzado, Josep Maria Campistol

    Contributions to Nephrology
    |February 8, 2012
    PubMed

    Insights

    Chronic hepatitis C virus (HCV) infection impacts survival in end-stage renal failure (ESRF) patients. Antiviral therapy before kidney transplant is recommended for improved outcomes and to mitigate liver disease progression.

    Area of Science:

    • Nephrology
    • Hepatology
    • Virology

    Background:

    • Chronic hepatitis C virus (HCV) infection is prevalent in end-stage renal failure (ESRF) patients, negatively affecting survival and liver health.
    • HCV progresses to cirrhosis in 20% of cases within 20 years.
    • Current interferon-based therapies offer limited cure rates (30-45%) in ESRF patients.

    Purpose of the Study:

    • To review current treatment options for chronic HCV in ESRF patients.
    • To evaluate the benefits of pre-transplant antiviral therapy in HCV-positive kidney transplant candidates.
    • To emphasize individualized treatment decisions for dialysis patients.

    Main Methods:

    • Literature review of HCV treatment in ESRF and kidney transplant populations.
    • Analysis of treatment efficacy and tolerance of interferon (IFN) and ribavirin (RBV).
    • Assessment of risks associated with HCV in kidney transplant recipients.

    Main Results:

    • Interferon-based therapies are the primary treatment for HCV in ESRF patients.
    • Ribavirin combination therapy shows higher sustained virological response rates but has poor tolerance in ESRF patients.
    • Pre-transplant antiviral treatment is crucial for HCV-positive kidney transplant candidates due to improved life expectancy and risks of immunosuppression.

    Conclusions:

    • Antiviral treatment for HCV in dialysis patients requires individualized assessment.
    • HCV-positive kidney transplant candidates should be evaluated for pre-transplant antiviral therapy.
    • Early treatment can improve outcomes and reduce liver disease progression in this vulnerable population.

    More Related Videos

    A Protocol for Analyzing Hepatitis C Virus Replication13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    Related Concept Videos

    Dialysis01:27

    Dialysis

    Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
    Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
    Dialysis01:15

    Dialysis

    Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

    Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

    Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
    Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

    Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

    Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
    Hemodialysis I: Introduction01:25

    Hemodialysis I: Introduction

    Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...